Locations:

Blood Cancers

CAR T-cell therapy

Metabolomic Screening Reveals Pre-Existing Signatures in Patients Treated with CAR T-Cell Therapy

Molecular markers could potentially predict major adverse side effects

650×450-Central-Nervous-System-Lymphoma
October 28, 2020/Cancer/Blood Cancers

Standardizing Care for Central Nervous System Lymphoma

Emerging multidisciplinary program seeks better care, outcomes

BackPage 7 of 7Next

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

Ad